These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16856707)

  • 1. Azithromycin-induced QT prolongation in elderly patient.
    Russo V; Puzio G; Siniscalchi N
    Acta Biomed; 2006 Apr; 77(1):30-2. PubMed ID: 16856707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant inverted T waves and substantial QT interval prolongation induced by azithromycin in an elderly woman with renal insufficiency.
    Yu T; Niu T
    Can Fam Physician; 2014 Nov; 60(11):1012-5. PubMed ID: 25392441
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of QT-interval prolongation precipitated by azithromycin.
    Matsunaga N; Oki Y; Prigollini A
    N Z Med J; 2003 Nov; 116(1185):U666. PubMed ID: 14615808
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphic ventricular tachycardia with a normal QT interval following azithromycin.
    Kim MH; Berkowitz C; Trohman RG
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1221-2. PubMed ID: 16359290
    [No Abstract]   [Full Text] [Related]  

  • 6. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and extreme bradycardia after a single dose of azithromycin.
    Santos N; Oliveira M; Galrinho A; Oliveira JA; Ferreira L; Ferreira R
    Rev Port Cardiol; 2010 Jan; 29(1):139-42. PubMed ID: 20391905
    [No Abstract]   [Full Text] [Related]  

  • 8. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT prolongation associated with azithromycin/amiodarone combination.
    Samarendra P; Kumari S; Evans SJ; Sacchi TJ; Navarro V
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1572-4. PubMed ID: 11707055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible azithromycin-associated hiccups.
    Jover F; Cuadrado JM; Merino J
    J Clin Pharm Ther; 2005 Aug; 30(4):413-6. PubMed ID: 15985056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sibutramine-associated QT interval prolongation and cardiac arrest.
    Ernest D; Gershenzon A; Corallo CE; Nagappan R
    Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin-induced agitation and choreoathetosis.
    Farooq O; Memon Z; Stojanovski SD; Faden HS
    Pediatr Neurol; 2011 Apr; 44(4):311-3. PubMed ID: 21397177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig.
    Fossa AA; Wisialowski T; Duncan JN; Deng S; Dunne M
    Am J Trop Med Hyg; 2007 Nov; 77(5):929-38. PubMed ID: 17984356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.